How do you pay?

How to pay the least

From

$12.25 for 30 tablets delivered ($7 plus $5.25 shipping)

Generic flecainide from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic flecainide. It comes by mail.

Need it today? From $14.81 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

With a membership From $9.36 for 30 tablets from Amazon Pharmacy, by mail ($139 a year).

Open Amazon Pharmacy 

A regular generic has the same active ingredient as Tambocor, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameTambocor
Authorized genericflecainide
Regular genericflecainide
What you’d pay
Not soldNo longer sold
Not soldNo longer sold
From$12.25for 30 tablets at Cost Plus Drugs, with shipping
Same as Tambocor?
–
–
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Tambocor itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the regular generic →

Authorized genericNot sold now

An authorized generic of Tambocor was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (flecainide acetate) is available.

Source: FDA, updated October 30, 2026

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic flecainide, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

7 companies sell a generic of Tambocor that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Amneal Pharmaceuticals50 mg, 100 mg, 150 mg
    Packages and NDCs

    50 mg White, round, 7 mm, marked “AN / 641”

    PackageNDC
    Bottle of 10053746-641-01
    Bottle of 100053746-641-10

    50 mg White, round, 7 mm, marked “AN / 641”

    PackageNDC
    Bottle of 10065162-641-10
    Bottle of 100065162-641-11

    100 mg White, round, 9 mm, marked “AN / 642”

    PackageNDC
    Bottle of 10053746-642-01
    Bottle of 100053746-642-10

    100 mg White, round, 9 mm, marked “AN / 642”

    PackageNDC
    Bottle of 10065162-642-10
    Bottle of 100065162-642-11

    150 mg White, oval, 13 mm, marked “AN / 643”

    PackageNDC
    Bottle of 10053746-643-01
    Bottle of 100053746-643-10

    150 mg White, oval, 13 mm, marked “AN / 643”

    PackageNDC
    Bottle of 10065162-643-10
    Bottle of 100065162-643-11

    FDA label

  • ANI Pharmaceuticals50 mg, 100 mg, 150 mg

    Product page on anipharmaceuticals.com

    How it looks, what’s in it, NDCs

    50 mg Off-white, round, 7 mm, marked “ANI / 380”

    PackageNDC
    Bottle of 10062559-380-01

    100 mg Off-white, oval, 12 mm, marked “ANI / 381 / 100”

    PackageNDC
    Bottle of 10062559-381-01

    150 mg Off-white, oval, 14 mm, marked “ANI / 382 / 150”

    PackageNDC
    Bottle of 10062559-382-01

    Inactive ingredients: silicon dioxide, microcrystalline cellulose, starch, corn, croscarmellose sodium, sodium stearyl fumarate, magnesium stearate

    FDA label

  • Aurobindo Pharma50 mg, 100 mg, 150 mg

    Product page on aurobindousa.com

    How it looks, what’s in it, NDCs

    50 mg White to Off-white, round, 7 mm, marked “CC / 11”

    PackageNDC
    Bottle of 3065862-621-30
    Bottle of 10065862-621-01
    Bottle of 100065862-621-99

    100 mg White to Off-white, round, 9 mm, marked “1 / 2 / CC”

    PackageNDC
    Bottle of 3065862-622-30
    Bottle of 10065862-622-01
    Bottle of 100065862-622-99

    150 mg White to Off-white, oval, 13 mm, marked “1 / 3 / CC”

    PackageNDC
    Bottle of 3065862-623-30
    Bottle of 10065862-623-01
    Bottle of 100065862-623-99

    Inactive ingredients: croscarmellose sodium, hydrogenated cottonseed oil, magnesium stearate, microcrystalline cellulose, starch, corn

    FDA label

  • Epic Pharma50 mg, 100 mg, 150 mg

    Made by Yichang Humanwell Pharmaceutical

    Product page on epic-pharma.com

    How it looks, what’s in it, NDCs

    50 mg White, round, 6 mm, marked “YH / 777”

    PackageNDC
    Bottle of 10042806-817-01

    100 mg White, round, 9 mm, marked “YH / 717”

    PackageNDC
    Bottle of 10042806-818-01

    150 mg White, capsule, 14 mm, marked “YH / 711”

    PackageNDC
    Bottle of 10042806-819-01

    Inactive ingredients: magnesium stearate, microcrystalline cellulose, croscarmellose sodium, starch, corn

    FDA label

  • Hikma Pharmaceuticals50 mg, 100 mg, 150 mg
    How it looks, what’s in it, NDCs

    50 mg White, round, 6 mm, marked “54024”

    PackageNDC
    Bottle of 600054-0010-21
    Carton of 1000054-0010-20
    Bottle of 1000054-0010-25

    100 mg White, round, 8 mm, marked “54070”

    PackageNDC
    Bottle of 600054-0011-21
    Carton of 1000054-0011-20
    Bottle of 1000054-0011-25

    150 mg White, capsule, 14 mm, marked “54150”

    PackageNDC
    Bottle of 600054-0012-21
    Carton of 1000054-0012-20
    Bottle of 1000054-0012-25

    Inactive ingredients: magnesium stearate, microcrystalline cellulose, croscarmellose sodium, starch, corn, hydrogenated cottonseed oil

    FDA label

  • Rising Pharma Holdings50 mg, 100 mg, 150 mg

    Made by Aurobindo Pharma

    How it looks, what’s in it, NDCs

    50 mg White to Off-white, round, 7 mm, marked “CC / 11”

    PackageNDC
    Bottle of 10057237-063-01

    100 mg White to Off-white, round, 9 mm, marked “1 / 2 / CC”

    PackageNDC
    Bottle of 10057237-064-01

    150 mg White to Off-white, oval, 13 mm, marked “1 / 3 / CC”

    PackageNDC
    Bottle of 10057237-065-01

    Inactive ingredients: croscarmellose sodium, hydrogenated cottonseed oil, magnesium stearate, microcrystalline cellulose, starch, corn

    FDA label

  • Unichem Pharmaceuticals50 mg, 100 mg, 150 mg

    Made by Regcon Holdings

    Product page on unichemusa.com

    How it looks, what’s in it, NDCs

    50 mg White, round, 7 mm, marked “BPL025”

    PackageNDC
    Bottle of 6076385-145-60
    Bottle of 10076385-145-01

    100 mg White, round, 9 mm, marked “BPL026”

    PackageNDC
    Bottle of 6076385-146-60
    Bottle of 10076385-146-01

    150 mg White, capsule, 14 mm, marked “BPL027”

    PackageNDC
    Bottle of 6076385-147-60
    Bottle of 10076385-147-01

    Inactive ingredients: magnesium stearate, microcrystalline cellulose, croscarmellose sodium, starch, pregelatinized corn, hydrogenated olive oil, cellulose, microcrystalline

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

In patients without structural heart disease, flecainide acetate tablets, USP are indicated for the prevention of — paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms — paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms Flecainide acetate tablets, USP are also indicated for the prevention of — documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgment of the physician are life-threatening. Use of flecainide acetate tablets, USP for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide acetate tablets, USP are not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic. Because of the proarrhythmic effects of flecainide acetate tablets, USP, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks. Flecainide acetate tablets, USP should not be used in patients with recent myocardial infarction. (See BOXED WARNINGS.) Use of flecainide acetate tablets, USP in chronic atrial fibrillation has not been adequately studied and is not recommended. (See BOXED WARNINGS.) As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of flecainide acetate tablets, USP favorably affects survival or the incidence of sudden death.

Source: the FDA label for Flecainide Acetate (Aurobindo Pharma Limited), January 9, 2024. Full label on DailyMed